Pharmaceutical major Wockhardt Ltd. is going to shift its focus to drug discovery and biologics after exiting the US generics ...

A new study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...

Prof. Hening Lin brings expertise in enzymes to UChicago, bridging scientists, engineers and doctors to translate research to ...

"Synthetic biology tools like optogenetics allow us to precisely tune complex cellular processes, something traditional drug screening cannot do," said Maxwell Wilson, Ph.D., Co-Founder and Chief ...

A novel optogenetic screening platform enables a high-throughput screen and identified several integrated stress response-potentiating compounds.

Molecular glues, tiny molecules that connect one protein to another, are promising targets for pharmaceutical research. By ...

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

President Trump signed an executive order aiming to cut prescription drug costs by bringing the price the U.S. pays in line with comparable developed nations.

(RTTNews) - XtalPi (2228.HK) announced an expanded research collaboration with Pfizer (PFE) to develop a next-generation molecular modeling platform for drug discovery. The initiative aims to ...

In the collaboration, XtalPi will deploy its XFEP platform, from parameter customization to FEP calculations, for Pfizer to use in its drug discovery efforts.

1 Department of Pharmaceutical Sciences, College of Pharmacy, Howard University, Washington, D.C., United States 2 Artificial Intelligence and Drug Discovery (AIDD) Core Laboratory for District of ...